8-K
filed June 11, 2024, 7:59 PM ET
CIK 0001654151
M&A
confidence high
sentiment neutral
materiality 0.90
Deciphera Pharmaceuticals, Inc.: M&A transaction — Ono completes $2.4B acquisition of Deciphera; shares converted at $25.60 each
Deciphera Pharmaceuticals, Inc.
- 88.3% of shares tendered; all conditions satisfied; merger effective June 11, 2024.
- Each share converted to $25.60 cash; total consideration approx. $2.4 billion.
- Deciphera becomes wholly owned subsidiary of Ono; board replaced by Toichi Takino and Masayuki Tanigawa.
- Nasdaq listing suspended; Form 15 to be filed to terminate SEC reporting obligations.
- 2024 Annual Meeting cancelled due to closing of the merger.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Toichi Takino was appointed as Director at Deciphera Pharmaceuticals, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Toichi Takino and Masayuki Tanigawa became members of Deciphera’s board of directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dennis L. Walsh resigned as Director at Deciphera Pharmaceuticals, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
James A. Bristol resigned as Director at Deciphera Pharmaceuticals, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ron Squarer resigned as Director at Deciphera Pharmaceuticals, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Frank S. Friedman resigned as Director at Deciphera Pharmaceuticals, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Patricia L. Allen resigned as Director at Deciphera Pharmaceuticals, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Susan L. Kelley resigned as Director at Deciphera Pharmaceuticals, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Edward J. Benz, Jr. resigned as Director at Deciphera Pharmaceuticals, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Masayuki Tanigawa was appointed as Director at Deciphera Pharmaceuticals, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Toichi Takino and Masayuki Tanigawa became members of Deciphera’s board of directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John R. Martin resigned as Director at Deciphera Pharmaceuticals, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Deciphera Pharmaceuticals, Inc. underwent a change of control involving Ono Pharmaceutical Co., Ltd. for $25.60 per share in cash (closed 2024-06-11).
- Action
- change of control
- Counterparty
- Ono Pharmaceutical Co., Ltd.
- Consideration
- $25.60 per share in cash
- Closing
- 2024-06-11
Exact text from the filing
May 13, 2024 to acquire all of the issued and outstanding shares of common stock, par value $0.01 per share, of the Company (“ Company Common Stock ”), at a price per share of $25.60, net to the seller in cash, without interest and subject to any withholding of taxes required by applicable law. The Offer and related withdrawal rights expired at one minute
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.